2-205047642-G-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001302769.2(PARD3B):c.456G>T(p.Gln152His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000251 in 1,550,886 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q152P) has been classified as Uncertain significance.
Frequency
Consequence
NM_001302769.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152154Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000647 AC: 1AN: 154594 AF XY: 0.0000122 show subpopulations
GnomAD4 exome AF: 0.0000272 AC: 38AN: 1398732Hom.: 0 Cov.: 30 AF XY: 0.0000290 AC XY: 20AN XY: 689950 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152154Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74318 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.456G>T (p.Q152H) alteration is located in exon 4 (coding exon 4) of the PARD3B gene. This alteration results from a G to T substitution at nucleotide position 456, causing the glutamine (Q) at amino acid position 152 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at